On April 12, 2019, the U.S. Consumer Product Safety Commission (CPSC) announced that Fisher-Price was recalling about 4.7 million Rock ’n Play infant sleepers because
Rheumatologists have a few pharmaceutical options for patients who are suffering from the effects of rheumatoid arthritis. One of those options is tofacitinib citrate, which
The FDA recently determined that Takeda Pharmaceutical’s medication, Uloric (febuxostat), should no longer be recommended as a first-line treatment for gout, a type of arthritis.
According to a recent announcement from Xeljanz manufacturer Pfizer, the company has taken steps to transition patients with rheumatoid arthritis (RA) who are taking the